2026 Summer Intern – IT-IS at Acadia Pharmaceuticals

Parsippany, New Jersey, United States

Apply Now

Not SpecifiedCompensation

InternshipExperience Level

InternshipJob Type

UnknownVisa

Biopharmaceutical, PharmaceuticalIndustries

Requirements

Pursuing an undergraduate or graduate degree in science, engineering, or other relevant IT field
Strong technical writing skills
Willingness to build interpersonal and communication skills
Experience with AI and/or Data Analytics
Must be able to work onsite at the Parsippany, NJ office 5 days per week
Ability to complete the entire 10-week program (from May 26, 2026 to July 31, 2026) and commit to 37.5 hours per week
Cumulative 3.0 GPA or above; college transcript required (must mail official transcript by application deadline)
Currently enrolled in an accredited U.S. based college or university
Enrolled in either an undergraduate (Bachelor’s), graduate, MBA, JD, PharmD, or PhD program
Legally authorized to work in the U.S. without a need for sponsorship/CPT/OPT now or in the future
At least 18 years of age prior to the scheduled start date
Must be available to complete virtual interviews with HR and hiring manager
Must successfully pass a drug screen and background check prior to start date
Must complete a final presentation at the end of the 10-week program (mandatory)
Application deadline is January 9, 2026

Responsibilities

Explore AI and Data Analytics solutions to enhance productivity and quality
Support upgrade/new installation projects for the Quality Control Laboratory systems
Draft Computer System Validation deliverables including User Requirements, System Assessments, Data Integrity Checklists, Validation Protocols, and Test Scripts
Learn and assist with system configuration, server infrastructure setup, troubleshooting for standalone systems and Automation
Manage project timelines
Interact with different stakeholders including Server infrastructure teams, Quality Assurance, Quality Control Chemists, Quality Control Microbiologists, Infrastructure, Production, Packaging, and Maintenance

Skills

Data Analytics

LIMS

CDMS

Computer System Validation

21 CFR Part 11

FDA Compliance

Serialization

Electronic Batch Record

User Requirements

Validation Protocols

Acadia Pharmaceuticals

Develops therapies for neurological disorders

About Acadia Pharmaceuticals

Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. The company conducts extensive research and clinical trials to create drugs that are safe and effective, seeking approval from regulatory bodies like the FDA before bringing them to market. Acadia differentiates itself by targeting areas with significant unmet medical needs, ensuring that their products address critical health challenges. Their goal is to improve the quality of life for patients suffering from these disorders while also promoting diversity, equity, and inclusion within their operations.

Dallas, TexasHeadquarters

1993Year Founded

$813.4MTotal Funding

ACQUISITIONCompany Stage

Biotechnology, HealthcareIndustries

501-1,000Employees

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Employee Stock Purchase Plan

Paid Vacation

Paid Holidays

Paid Sick Leave

Paid Parental Leave

Tuition Reimbursement

Risks

Increased competition in CNS drug market may impact Acadia's market share.

Potential clinical trial delays could affect drug approval timelines.

Dependence on partnerships poses risks if collaborations face challenges or dissolve.

Differentiation

Acadia focuses on CNS disorders with unmet medical needs, like Parkinson's and Rett syndrome.

The company has a strong R&D foundation, developing innovative small molecule drugs.

Acadia's strategic partnerships enhance its research capabilities and market reach.

Upsides

Acadia's collaboration with Saniona expands its portfolio with SAN711 for neurological disorders.

Health Canada's approval of Daybue boosts Acadia's presence in the Canadian market.

The rise of personalized medicine aligns with Acadia's targeted therapy approach.

Land your dream remote job 3x faster with AI

Try Jobo Free